Clinical Research Directory
Browse clinical research sites, groups, and studies.
Probiotics in Newly Diagnosed T1D
Sponsor: Medical College of Wisconsin
Summary
The investigators aim to further the understanding of environmental factors that underlie the development of Type 1 diabetes (T1D) and the post-onset disease trajectory. Dysbiosis, defined as alterations in intestinal microbiota composition and function, has been hypothesized to increase the risk of developing T1D in those with genetic susceptibility. Dysbiosis may result from modern dietary habits, such as broad consumption of the highly processed Western Diet, or by widespread use of antibiotics. Here, the investigators propose to examine the impact of dysbiosis on the endogenous innate inflammatory state that potentiates T1D progression. The investigators hypothesize that probiotic-induced alterations in the intestinal microbiota may favorably alter the post-onset disease state.
Official title: Probiotic-induced Normalization of Innate Inflammation in Youth Newly Diagnosed With Type 1 Diabetes
Key Details
Gender
All
Age Range
5 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
43
Start Date
2019-04-01
Completion Date
2027-06-30
Last Updated
2025-10-16
Healthy Volunteers
No
Interventions
Visbiome
This group will receive Visbiome probiotic in powder form.
Placebo
This group will receive a placebo in powder form.
Locations (1)
Medical College of Wisconsin
Milwaukee, Wisconsin, United States